The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation

Prog Clin Biol Res. 1990:338:121-8.

Authors

W P Peters¹, J Kurtzberg, S Atwater, M Borowitz, M Rao, M Currie, C Gilbert, E J Shpall, R B Jones, M Ross

Affiliation

¹ Duke University Bone Marrow Transplant Program, Department of Medicine, Pathology.

PMID: 2189135

No abstract available

Publication types

Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow / drug effects
Bone Marrow / pathology
Bone Marrow Transplantation*
Breast Neoplasms / therapy
Cell Migration Inhibition
Clinical Trials as Topic
Colony-Stimulating Factors / therapeutic use*
Combined Modality Therapy
Female
Granulocyte-Macrophage Colony-Stimulating Factor
Granulocytes / drug effects
Growth Substances / therapeutic use*
Humans
Leukocyte Count
Melanoma / therapy
Oxygen Consumption / drug effects
Phagocytosis / drug effects
Recombinant Proteins / therapeutic use
Transplantation, Autologous

Substances

Colony-Stimulating Factors
Growth Substances
Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor